PRA Clinical Pharmacology Center — Lenexa, Kansas

PRA Clinical Pharmacology Center is a clinical research site located in Lenexa, Kansas, United States 66219.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PRA Clinical Pharmacology Center has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: PLx Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lenexa

Browse all research sites in Kansas · View every site in Lenexa

• Minimally Invasive Surgery Hospital
• Johnson County Clin-Trials
• Kansas Institute of Medicine Cancer and Blood Center
• GSK Investigational Site
• Johnson County Clinical Trials
• Pra International
• Retina Associates
• ICON Lenexa
• Pharmaceutical Research Associates, Inc
• PRA Health Sciences
• Research Site
• ICON plc

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PRA Clinical Pharmacology Center?

PRA Clinical Pharmacology Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PRA Clinical Pharmacology Center conducted?

PRA Clinical Pharmacology Center has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is PRA Clinical Pharmacology Center accredited by Crixeo Clinical Trials?

PRA Clinical Pharmacology Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PRA Clinical Pharmacology Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.